Leptin, the product of the OB gene, is increased in obese individuals, suggesting resistance to its effect. We questioned whether subjects with NIDDM have an altered regulation of serum leptin levels. We used a radioimmunoassay to measure serum leptin levels in three groups from the San Antonio Heart Study: 1) 50 Mexican-Americans with NIDDM; 2 ) 50 nondiabetic Mexican-Americans matched by age and sex to the diabetic Mexican-Americans; and 3 ) 50 nondiabetic Mexican-Americans matched by age, sex, and BMI to the diabetic Mexican-Americans. Leptin concentrations did not differ significantly by diabetic status. Leptin concentrations were significantly correlated with BMI in all groups (NIDDM women: r -0.637; nondiabetic women: r = 0.772; NIDDM men: r = 0.849; and nondiabetic men: r = 0.686; all P < 0.001). Leptin levels were higher in women than in men regardless of diabetic status. We concluded that the leptin concentrations were not different in diabetic and nondiabetic subjects and that the association of leptin with obesity was similar in diabetic and nondiabetic subjects.
O besity is strongly associated with the development of NIDDM (1) (2) (3) . Both NIDDM (4, 5) and obesity (6, 7) have strong familial components. A commonly used animal model to study genetics of obesity has been the ob/ob mouse (8, 9) . Recently, the gene responsible for obesity in this animal model was cloned, along with its analog in humans (10) . The OB gene is expressed in human tissues, especially adipose tissue (11) (12) (13) . Since obese humans overexpress the gene product, leptin, it has been suggested that such subjects may be resistant to the effects of leptin (12) (13) (14) . Administration of the obese gene product to ob/ob mice reduces their body weight (15) . Assays for detection of leptin in human plasma have been developed (16) (17) (18) , and it has been shown that obese humans have increased levels of leptin (16, 17) . Furthermore, leptin levels decline in subjects who lose weight (16, 17) . Because there is variability in leptin levels at a given level of BMI (16, 17) , there may be variations in the secretion rate of leptin from adipose tissue; alternatively, environmental factors other than obesity may regulate leptin concentrations.
We questioned whether the regulation of leptin levels might be altered in NIDDM. To examine this possibility, we examined leptin concentrations in three groups of subjects: i ) 50 diabetic Mexican-Americans; 2) 50 nondiabetic Mexican-Americans (control group 1) matched to the NIDDM subjects for age and sex; and 5) 50 nondiabetic MexicanAmericans (control group 2) matched to the NIDDM subjects for age, sex, and BMI. Subjects were participants in the San Antonio Heart Study, a population-based study of diabetes (19) . Mexican-Americans have been previously shown to have high rates of obesity and diabetes (19) .
RESEARCH DESIGN AND METHODS
The San Antonio Heart Study is a population-based study of diabetes and cardiovascular disease in Mexican-Americans and non-Hispanic whites. From 1979 to 1982 (phase I) and from 1984 to 1988 (phase II), we randomly selected households from low-income (barrio), middle-income (transitional), and high-income (suburban) census tracts in San Antonio, Texas (19, 20) . All men and nonpregnant women ages 25-64 years who resided in the randomly selected households were eligible to participate. Only Mexican-Americans were sampled in the barrio, but approximately equal numbers of each ethnic group were studied in the other types of neighborhoods. Mexican-Americans were defined as individuals whose ancestry and cultural traditions derived from Mexican national origin. Detailed descriptions of the two study phases (I and II) have been published previously (19, 20) . This study was approved by the Institutional Review Board of the University of Texas Health Science Center at San Antonio. All subjects gave informed consent.
In October 1987, we began an 8-year follow-up of the phase I cohort to determine the incidence of NIDDM and cardiovascular disease (3). Beginning in October 1991, we began a similar 7-year follow-up of the phase II cohort (21) . The results reported in this paper are based on cross-sectional analyses of the 7-year follow-up of the phase II cohort. Fifty Mexican-American subjects with NIDDM were matched to 50 nondiabetic subjects (group 1) for age (±5 years), sex, and ethnicity. A second control group of nondiabetic subjects (group 2) was matched to the diabetic group by BMI (±2 units kg/m 2 ) as well as age, sex, and ethnicity. Diabetic case patients were chosen at random from among subjects for whom serum contingency samples were available. Control subjects were listed in random order, and for each case patient, the first control subject who met the matching criteria was selected.
At the follow-up of the phase II cohort, blood specimens were obtained after a 12-to 14-h fast for determination of plasma glucose concentrations. A 75-g glucose equivalent load (Koladex or Orangedex, Custom Laboratories, Baltimore, MD) was administered, and blood specimens were obtained 2 h later for plasma glucose concentrations. Diabetes was diagnosed according to World Health Organization criteria. Glucose was measured by a glucose oxidase method. Subjects who were classified as having IDDM on the basis of insulin use, lack of obesity (BMI <30 kg/m 2 ), and early onset of diabetes (before age 40 years) were excluded from being selected for any of the three groups.
Serum samples later used for leptin determinations were stored at -70°C for an average duration of 2.8 years. These samples were not thawed until the leptin assay was performed. Leptin was measured by a commercial radioimmunoassay (Linco Research, St. Louis, MO) (18) . The within-assay coefficient of variation was 3.4-8.3% and betweenassay coefficient of variation was 3.6-6.2%.
Statistical analyses included analyses of variance, Spearman correlation coefficients, and multiple linear regression. 
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RESULTS
Diabetic subjects had slightly higher leptin concentrations than the nondiabetic control group matched by age and sex (control group 1), although these differences were not statistically significant (23.1 ± 2.9 vs. 20.7 ± 2 . 1 ng/ml, P = 0.500) ( Table 1 ). These two groups were well matched for age and sex, although the diabetic group had a higher BMI than the nondiabetic group. The diabetic group had leptin concentrations virtually identical to those of the nondiabetic group matched for age, sex, and BMI (control group 2) (23.1 ± 2.9 vs. 23.5 ± 2.2 ng/ml, P = 0.911). When we combined the two nondiabetic groups and compared diabetic and nondiabetic groups separately by sex, women had significantly higher leptin concentrations than men (NIDDM women: 33.6 ± 2.5 ng/ml; nondiabetic women: 29.7 ± 1.7 ng/ml; NIDDM men: 8.3 ± 3.2 ng/ml; and nondiabetic men: 10.0 ± 2.3 ng/ml). The correlation between BMI and leptin concentration was similar in each group (NIDDM women: r -0.637; nondiabetic women: r = 0.772; NIDDM men: r = 0.849; and nondiabetic men: r = 0.686; all P < 0.0001). We also fit a multiple linear regression model with plasma leptin concentrations as a dependent variable (Table 2) . Increased BMI, female sex, and age were significantly associated with higher leptin concentrations. Diabetic status was not significantly associated with leptin concentration. We repeated multiple linear regression analyses in the 100 nondiabetic subjects; neither fasting nor 2-h glucose levels were significantly related to leptin concentrations (data not shown).
DISCUSSION
We have shown that leptin concentrations are not increased in NIDDM subjects compared with those in nondiabetic subjects. Furthermore, the association between obesity (as measured by BMI) and leptin concentration was similar in NIDDM and nondiabetic subjects. In a recent report (17) , serum leptin was correlated with BMI (r = 0.66) and body fat (by bioimpedance) (?~ = 0.85), which is similar to the correlations observed in the present study. Serum glucose levels were not correlated with leptin levels (17), although it was not specified in that report whether any of the subjects had diabetes. In another report (16) , the correlation of leptin with BMI was 0.51 whereas a stronger correlation with percentage body fat (by underwater weighing) was observed (r = 0.85). Although there was a considerable range of leptin concentrations at each level of obesity, we have concluded that diabetes does not explain this residual variance in leptin concentrations.
In this study, older subjects had moderately higher leptin concentrations. In a previous report (17) , leptin levels were not significantly related to age. We cannot exclude the possibility that the higher leptin levels in older subjects may be due to a higher percentage adiposity at the same level of BMI because we did not measure percentage adiposity. We also found significantly higher leptin concentrations in women than in men. This too may result from women having higher adiposity at a given level of BMI than men.
Leptin is produced in adipose tissue (11) (12) (13) (14) . Leptin is absent in obese ob/ob mice, which is responsible for their obesity (22) . In contrast, the db mouse has increased leptin concentrations, suggesting a resistance to the effect of leptin (22) . The db mouse appears to be a closer model for most human obesity. Although obese humans may be relatively resistant to leptin, reduction in body weight is associated with decreases in leptin concentration (16, 17) . It appears that leptin may represent a product of the adipose tissue that informs the brain about the size of the adipose tissue depot (23, 24) . The action of leptin on the brain in rodents may be at the level of the hypothalamus (23, 25) . Recently, a leptinbinding receptor, OB-R, that is expressed in the mouse choroid plexus has been cloned (26) . The observed decreases in leptin concentrations in obese humans after weight reduction (16, 17) may in part explain the high rate of relapse after weight reduction and the increased hunger and decreased energy expenditure (27) .
Although there is considerable residual variability in leptin concentrations at each level of adiposity, our data indicate that diabetes does not account for this variability. Our data further suggest that the relation between leptin and obesity is similar in diabetic and nondiabetic subjects.
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